Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Control Trial to Compare the Live Birth Rate Between Intracytoplasmic Sperm Injection and Artificial Oocyte Activation and Intracytoplasmic Sperm Injection Alone in Patients With Severe Teratospermia

NCT06561451 is registered in ClinicalTrials.gov with ShangHai Ji Ai Genetics & IVF Institute as lead sponsor.

NCT NCT06561451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06561451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Control Trial to Compare the Live Birth Rate Between Intracytoplasmic Sperm Injection and Artificial Oocyte Activation and Intracytoplasmic Sperm Injection Alone in Patients With Severe Teratospermia
Lead sponsor
ShangHai Ji Ai Genetics & IVF Institute
Phase
Not applicable
Overall status
Recruiting
Start date
August 30, 2024
Completion date
December 30, 2027
Enrollment
208 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility, teratospermia